Innova Captab Limited (INNOVACAP.NS)
INR 875.7
(5.21%)
INR 875.7
(5.21%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 10.81 Billion INR | 16.72% |
| 2022 | 9.26 Billion INR | 15.83% |
| 2021 | 7.99 Billion INR | 95.27% |
| 2020 | 4.09 Billion INR | 9.71% |
| 2019 | 3.73 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 2.94 Billion INR | 12.05% |
| 2023 Q2 | 2.82 Billion INR | 21.51% |
| 2023 Q3 | 3.02 Billion INR | 6.91% |
| 2023 Q1 | 2.32 Billion INR | -46.24% |
| 2023 FY | 10.81 Billion INR | 16.72% |
| 2023 Q4 | 2.62 Billion INR | -13.17% |
| 2022 Q3 | 2.42 Billion INR | 0.0% |
| 2022 FY | 9.26 Billion INR | 15.83% |
| 2022 Q4 | 4.33 Billion INR | 78.99% |
| 2021 FY | 7.99 Billion INR | 95.27% |
| 2020 FY | 4.09 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | 82.309% |
| Hester Biosciences Limited | 3.04 Billion INR | -255.055% |
| Aarti Drugs Limited | 25.28 Billion INR | 57.237% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | 40.441% |
| Albert David Limited | 3.62 Billion INR | -198.323% |
| Alembic Limited | 1.57 Billion INR | -586.607% |
| Alkem Laboratories Limited | 126.67 Billion INR | 91.464% |
| Bafna Pharmaceuticals Limited | 1.52 Billion INR | -609.212% |
| Bajaj HealthCare Limited | 4.73 Billion INR | -128.404% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -2600.879% |
| Brooks Laboratories Limited | 794.86 Million INR | -1260.37% |
| Eris Lifesciences Limited | 20.09 Billion INR | 46.181% |
| FDC Limited | 19.42 Billion INR | 44.347% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | 52.641% |
| Gufic Biosciences Limited | 8.06 Billion INR | -34.046% |
| Hikal Limited | 17.84 Billion INR | 39.409% |
| Ind-Swift Limited | 5.02 Billion INR | -115.199% |
| IOL Chemicals and Pharmaceuticals Limited | 21.32 Billion INR | 49.301% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -418.11% |
| Jubilant Pharmova Limited | 67.02 Billion INR | 83.868% |
| Lincoln Pharmaceuticals Limited | 5.8 Billion INR | -86.255% |
| Lupin Limited | 196.56 Billion INR | 94.499% |
| Mangalam Drugs & Organics Limited | 3.67 Billion INR | -194.35% |
| Medico Remedies Limited | 1.44 Billion INR | -646.136% |
| Morepen Laboratories Limited | 17.01 Billion INR | 36.465% |
| Nectar Lifesciences Limited | 16.84 Billion INR | 35.811% |
| Orchid Pharma Limited | 8.19 Billion INR | -31.968% |
| Procter & Gamble Health Limited | 11.51 Billion INR | 6.076% |
| RPG Life Sciences Limited | 5.82 Billion INR | -85.775% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -600.452% |
| Sigachi Industries Limited | 3.98 Billion INR | -171.034% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | 12.685% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | -2.849% |
| Themis Medicare Limited | 3.81 Billion INR | -183.241% |
| Unichem Laboratories Limited | 16.57 Billion INR | 34.76% |
| Vaishali Pharma Limited | 862.79 Million INR | -1153.255% |
| Wanbury Limited | 5.75 Billion INR | -87.841% |
| Windlas Biotech Limited | 6.3 Billion INR | -71.376% |
| ZIM Laboratories Limited | 3.67 Billion INR | -194.219% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | 15.582% |
| Ipca Laboratories Limited | 77.05 Billion INR | 85.968% |
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 97.77% |
| Venus Remedies Limited | 5.91 Billion INR | -82.823% |
| Sakar Healthcare Limited | 1.54 Billion INR | -601.384% |
| Aurobindo Pharma Limited | 290.01 Billion INR | 96.272% |
| Divi's Laboratories Limited | 78.45 Billion INR | 86.217% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | 16.536% |
| Mankind Pharma Limited | 103.34 Billion INR | 89.537% |
| Sequent Scientific Limited | 13.69 Billion INR | 21.057% |
| Laurus Labs Limited | 50.01 Billion INR | 78.382% |
| Neuland Laboratories Limited | 15.58 Billion INR | 30.622% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.47 Billion INR | 68.637% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 90.847% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 94.315% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | -156.701% |
| Wockhardt Limited | 27.89 Billion INR | 61.23% |
| Bal Pharma Limited | 3.39 Billion INR | -218.763% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 96.127% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | -40.385% |
| Par Drugs and Chemicals Limited | 956.4 Million INR | -1030.594% |
| Caplin Point Laboratories Limited | 16.76 Billion INR | 35.513% |
| Shilpa Medicare Limited | 11.53 Billion INR | 6.227% |
| Valiant Laboratories Limited | 1.82 Billion INR | -493.937% |
| Ajanta Pharma Limited | 42.08 Billion INR | 74.308% |
| Aarey Drugs & Pharmaceuticals Limited | 3.95 Billion INR | -173.321% |
| Granules India Limited | 45.06 Billion INR | 76.005% |
| Medicamen Biotech Limited | 1.79 Billion INR | -503.049% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -317.099% |
| Piramal Enterprises Limited | 60.33 Billion INR | 82.079% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | 89.804% |
| NATCO Pharma Limited | 40.02 Billion INR | 72.981% |
| Suven Life Sciences Limited | 116.92 Million INR | -9147.535% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -2044.532% |
| Strides Pharma Science Limited | 40.51 Billion INR | 73.309% |
| Indoco Remedies Limited | 18.17 Billion INR | 40.499% |
| Alpa Laboratories Limited | 1.08 Billion INR | -894.404% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -936.378% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -1331.333% |